GB9725346D0 - Pharmaceutical composition for the treatment of inflammatory bowel disease - Google Patents
Pharmaceutical composition for the treatment of inflammatory bowel diseaseInfo
- Publication number
- GB9725346D0 GB9725346D0 GBGB9725346.2A GB9725346A GB9725346D0 GB 9725346 D0 GB9725346 D0 GB 9725346D0 GB 9725346 A GB9725346 A GB 9725346A GB 9725346 D0 GB9725346 D0 GB 9725346D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- pharmaceutical composition
- inflammatory bowel
- bowel disease
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9725346.2A GB9725346D0 (en) | 1997-11-28 | 1997-11-28 | Pharmaceutical composition for the treatment of inflammatory bowel disease |
DE69824748T DE69824748T2 (en) | 1997-09-26 | 1998-09-25 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFUSED STOMACH DISEASES |
AU91780/98A AU758501B2 (en) | 1997-09-26 | 1998-09-25 | Pharmaceutical composition for the treatment of inflammatory bowel disease |
ES98944115T ES2224428T3 (en) | 1997-09-26 | 1998-09-25 | PHARMNACEUTICAL COMPOSITION FOR THE TREATMENT OF INTESTINAL INFLMATORY DISEASE. |
AT98944115T ATE269710T1 (en) | 1997-09-26 | 1998-09-25 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE |
DK98944115T DK1017404T3 (en) | 1997-09-26 | 1998-09-25 | Pharmaceutical composition for the treatment of inflammatory bowel disease |
CA002304948A CA2304948C (en) | 1997-09-26 | 1998-09-25 | Pharmaceutical composition for the treatment of inflammatory bowel disease |
US09/508,661 US7341741B1 (en) | 1997-09-26 | 1998-09-25 | Pharmaceutical composition for the treatment of inflammatory bowel disease |
EP98944115A EP1017404B1 (en) | 1997-09-26 | 1998-09-25 | Pharmaceutical composition for the treatment of inflammatory bowel disease |
PT98944115T PT1017404E (en) | 1997-09-26 | 1998-09-25 | PHARMACEUTICAL FORMULA FOR THE TREATMENT OF INFLAMMATORY DISEASE OF THE INTESTINE |
PCT/GB1998/002899 WO1999016454A1 (en) | 1997-09-26 | 1998-09-25 | Pharmaceutical composition for the treatment of inflammatory bowel disease |
JP2000513588A JP4180791B2 (en) | 1997-09-26 | 1998-09-25 | Pharmaceutical composition for treating inflammatory bowel disease |
JP2008018436A JP2008143914A (en) | 1997-09-26 | 2008-01-30 | Pharmaceutical composition for treating inflammatory bowel disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9725346.2A GB9725346D0 (en) | 1997-11-28 | 1997-11-28 | Pharmaceutical composition for the treatment of inflammatory bowel disease |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9725346D0 true GB9725346D0 (en) | 1998-01-28 |
Family
ID=10822890
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9725346.2A Ceased GB9725346D0 (en) | 1997-09-26 | 1997-11-28 | Pharmaceutical composition for the treatment of inflammatory bowel disease |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB9725346D0 (en) |
-
1997
- 1997-11-28 GB GBGB9725346.2A patent/GB9725346D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL132145A (en) | Compositions for treating inflammatory bowel disease and uses thereof | |
ZA987552B (en) | Pharmaceutical composition for combination of piperidino-alkanol-decongestant | |
IL125735A0 (en) | Pharmaceutical compositions for the treatment of glaucoma | |
HUP0103856A3 (en) | Pharmaceutical composition for the treatment of acute disorders | |
EP1240136A4 (en) | Use of biologically active vitamin d compounds for the prevention and treatment of inflammatory bowel disease | |
IL117417A (en) | Pharmaceutical composition comprising rapamycin for treating cardiac inflammatory disease and its preparation | |
AU2027595A (en) | Pharmaceutical composition for treating inflammatory bowel diseases | |
ZA988920B (en) | Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome | |
HUP0003851A3 (en) | Pharmaceutical composition for the treatment or prevention of glomerulopathy | |
KR970000230A (en) | Cappa-Opide agonist for the treatment of inflammatory bowel disease | |
GB9706842D0 (en) | Pharmaceutical compositions for the treatment of rhinitis | |
IL113263A0 (en) | Imidazo pyridine compounds and pharmaceutical compositions for the treatment of gastrointestinal diseases | |
IL121096A0 (en) | Pharmaceutical compositions for the treatment of liver disease | |
HUP9900309A3 (en) | Use of ridogrel for producing pharmaceutical compositions for the treatment of inflammatory bowel diseases | |
HUP0101514A3 (en) | Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine | |
HUP0003159A3 (en) | The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions | |
IL120005A (en) | Pharmaceutical compositions for the treatment of the eye | |
GB9725346D0 (en) | Pharmaceutical composition for the treatment of inflammatory bowel disease | |
HUP0000569A3 (en) | Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states | |
HUP9903685A3 (en) | Use of olanzapine for the preparation of pharmaceutical compositions treating excessive aggression | |
GB9817348D0 (en) | Pharmaceutical use of esters | |
ZA986324B (en) | Composition for the treatment of immunodeficiency disease | |
GB2354946B (en) | Means for the treatment of prion disease | |
KR100248098B1 (en) | Pharmaceutical composition for the treatment of dementia | |
HUP0001499A3 (en) | Use of 7alpha-methyl-17alpha-ethynyl-estrane derivative for producing pharmaceutical compositions for the treatment of atherosclerosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |